Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
SB-505124 is an inhibitor of activin receptor-like kinase 5 (ALK5), also known as TGF-ß receptor type 1 (TGF-ßRI), and ALK4 (IC50s = 47 and 129 nM, respectively).1 It is selective for ALK5 and ALK4 over a panel of 27 kinases at 10 µM. SB-505124 (5 µM) also inhibits ALK7-induced increases in phosphorylated SMAD2 levels in COS-1 cells overexpressing ALK7. It inhibits TGF-ß-induced but not TNF-a-induced apoptosis in Fao hepatocellular carcinoma cells when used at a concentration of 1 µM. SB-505124 (5 mg/eye) decreases intraocular pressure (IOP) and subconjunctival immune cell infiltration in a rabbit model of trabeculectomy.2
WARNING This product is not for human or veterinary use.
1. SB-
2. Suppression of transforming growth factor-